Ultrarapid lytic granule release from CTLs activates Ca2+-dependent synaptic resistance pathways in melanoma cells science.org/doi/10.1126/sc…

Want to know more about target cell resistance? read our latest review on the topic :) Greek Fire, Poison Arrows, and Scorpion Bombs: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes frontiersin.org/article/10.338…

Very nice review from the DynAct team's at CRCT-Oncopole : Resisting T cell attack: defense and repair mechanisms intrinsic to tumor cells - Trends in Cancer 12/2022. #Cancer 🔗bit.ly/3CeTZIP

This morning #DynAct from CRCT-Oncopole ran/marched 5km for supporting cancer patients and cancer research 🔬👩‍🔬🧪. Thanks La Ligue contre le Cancer de Haute-Garonne for organizing #Oncorun2023.

The "most wanted" beautiful review of our great "cell-death mechanims" expert, Dr. Brienne Mckenzie, on how target cell resist CTL attack , is now available for everyone to read. Enjoy your read :) and spread the word! doi.org/10.1016/j.trec…

Notre talentueuse post-doctorante, le Dr Roxana Khazen, présentera ses dernières données sur l'hétérogénéité fonctionnelle des #CTLs demain lors du 26e congrès annuel de l'association française de cytométrie à la session SP9. Ne manquez pas son poster : SP9-3. #AFC2023

A must read! Bravo for the exceptional study 🎉

Roxana Khazen chercheure dans l'équipe DynAct VALITUTTI LAB fait partie des 10 lauréats distingués fin décembre 2023 par la Fondation ARC dans le cadre d’un nouvel appel à projets. ➡️crct-inserm.fr/roxana-khazen-…

State of the art molecular immunology in an idyllic Tuscan landscape! Applications are open for the Lymphocyte Antigen Receptor Signalling Workshop at the Certosa di Pontignano 1-5 June 2024. ndorms.ox.ac.uk/events/lymphoc…

So proud of our talented Roxana Khazen leading a brilliant project on "cytotoxic T cells functional heterogeneity in cancer".

🎉Mark your calendars! 🗓️ The 2nd Young Scientists in Cancer Congress (YS2C) is happening in Montpellier on October 10-11. 🌟 Get ready for cutting-edge insights on new translational approaches in cancer therapy. Stay tuned! #YS2C_2024 #YS2C_GSO #CancerResearch

Don't miss this fantastic meeting!